Most Recent
Swiss pharmaceutical company Biogen has filed another lawsuit accusing an Australian generic drug manufacturer of infringing the patent for its blockbuster multiple sclerosis drug Tecfidera.
A judge has thrown out trade mark infringement claims brought by AGL against Greenpeace for using the energy company's logo in a public campaign labelling it "Australia's biggest climate polluter".
An appeals court has upheld a ruling which bars use of the RestQ trade mark on sleep products sold by Martin & Pleasance because of a “disturbing” number of similarities with the marketing and appearance of an established competitor’s Rescue natural sleep aid product.
A judge has issued an injunction temporarily barring use of the RestQ trade mark on sleep products sold by Martin & Pleasance because of a “disturbing” number of similarities with the marketing and appearance of an established competitor’s Rescue natural sleep aid product.
The Full Federal Court has been asked to consider an appeal of a judge's ruling backing the position of the Commissioner of Patents that two patents for a computer-implemented invention did not describe a manner of manufacture and should be revoked.
The Federal Court has once again sided with the Commissioner of Patents in a challenge to a ruling that patents for a computer-implemented invention did not describe a manner of manufacture and should be revoked.
Lawyerly's Litigation Firms of 2020 delivered significant victories for clients last year in bet-the-company matters, thriving in a tumultuous year that saw courts and litigants adapt to virtual trials and other new norms that are sure to outlast the COVID-19 pandemic.
US cryptocurrency maker Ripple Labs has reached a settlement with the company behind the PayID mobile banking system, ending months of litigation in their trade mark spat.
Neurim Pharmaceuticals can seek limited additional damages in a patent infringement case relating to its insomnia drug Circadin, after a judge granted a mid-trial bid to amend its pleadings against Generic Partners and Apotex.
Women's fashion designer Pinnacle Runway has cut its losses and dropped its challenge to a ruling that found a rival's use of the name 'Delphine' to describe a bikini style did not constitute trade mark infringement, after a judge hit the company with indemnity costs for pursuing the 'ill-advised' lawsuit.